[LIPO] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[LIPO] Lipella Pharmaceuticals Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -53.99%
YoY- -109,011.56%
Quarter Report
LIPO's Result
LIPO's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
Revenue 80 104,051 0 0 -
PBT -1,444,637 -1,324 -714 -525 1297.93%
Tax 0 33,124 -1 -523 -
NP -1,444,637 -1,324 -713 -525 1297.93%
Tax Rate - - - - -
Total Cost 1,444,717 105,375 713 525 1297.96%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
NP Margin -1,797,259.27 -1.27 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 CAGR
EPS -1.29 -0.23 -0.12 -0.09 142.71%
EPS Diluted -1.29 -0.23 -0.12 -0.09 142.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.